Elicio Therapeutics, Inc. (ELTX)
1.68
-0.07
(-4.00%)
USD |
NASDAQ |
Oct 30, 16:00
1.695
+0.02
(+0.89%)
After-Hours: 20:00
Elicio Therapeutics Total Assets (Quarterly) : 31.33M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.33M |
| March 31, 2026 | 22.69M |
| December 31, 2025 | 25.86M |
| September 30, 2025 | 28.28M |
| June 30, 2025 | 29.53M |
| March 31, 2025 | 28.14M |
| December 31, 2024 | 28.18M |
| September 30, 2024 | 38.39M |
| June 30, 2024 | 15.75M |
| March 31, 2024 | 24.48M |
| December 31, 2023 | 27.15M |
| September 30, 2023 | 30.99M |
| June 30, 2023 | 37.62M |
| March 31, 2023 | 41.77M |
| Date | Value |
|---|---|
| December 31, 2022 | 22.66M |
| September 30, 2022 | 61.32M |
| June 30, 2022 | |
| March 31, 2022 | 81.26M |
| December 31, 2021 | 96.51M |
| September 30, 2021 | 109.94M |
| June 30, 2021 | 125.36M |
| March 31, 2021 | 139.20M |
| December 31, 2020 | 47.35M |
| September 30, 2020 | 22.74M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 11.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 106.22M |
| Armata Pharmaceuticals, Inc. | 89.95M |
| Voyager Therapeutics, Inc. | 197.75M |
| Black Diamond Therapeutics, Inc. | 125.03M |
| Invivyd, Inc. | 218.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.39M |
| Shareholders Equity (Quarterly) | 7.937M |
| Debt to Equity Ratio | 1.782 |
| Current Ratio | 2.770 |
| Net Debt Paydown Yield | -1.95% |